5E Advanced Materials, Inc.

What they do

The company holds 100% of the 5E Boron Americas (Fort Cady) Complex in southern California through subsidiary 5E Boron Americas LLC, with borates contained in the mineral colemanite and an associated lithium resource. It currently operates a small-scale facility (SSF) that generates data for designing a future commercial-scale facility. It has not yet reached commercial production and describes itself as a development stage company.

Revenue drivers

• Boric acid — The intended primary product from the planned 130,000 short ton per annum boric acid plant under the August 2025 Preliminary Feasibility Study; no commercial production has been reported.
• Calcium chloride and gypsum co-products — Described as planned co-products of boron extraction at the commercial-scale facility, intended to be sold alongside borates.
• Lithium carbonate (potential) — The Project is underpinned by a lithium resource, and lithium carbonate is described only as a potential future byproduct.
• Advanced boron derivatives (potential) — Downstream advanced boron material processing is part of the stated strategy but appears to be a future-phase option rather than current revenue.

Recent performance

The company has reported net losses every year shown, including a $31.6M net loss for fiscal 2025 and a $62.0M loss for fiscal 2024. Operating cash flow has been negative annually, at -$23.6M in fiscal 2025 and -$26.9M in fiscal 2024. Diluted EPS was -$3.95 in fiscal 2025 and -$27.15 in fiscal 2024. As of March 31, 2026, the company reported total assets of $78.1M, total liabilities of $5.1M, shareholder equity of $73.0M and cash and equivalents of $25.4M, with no long-term debt. No product revenue figures are disclosed in the excerpts provided.

Strategy

Management's stated plan is to develop a vertically integrated borate business, starting with the SSF and moving toward a commercial-scale facility producing borates, calcium chloride and gypsum. The August 2025 PFS targeted a 130,000 short ton per annum boric acid plant, based on roughly 41% of total mineral resource, about 5.3 million short tons of boric acid reserves at 8.03% B2O3 grade and a 39.5-year initial mine life using in-situ leaching. The PFS cited an aggregate capital estimate of approximately $435M, including about $367M of capital, a 15% contingency of about $55M and owner's costs of about $13M, with capital estimates developed by Fluor and Miocene. The company also announced a voluntary ASX delisting in April 2026 while keeping its Nasdaq listing, and appointed Jonathan Siegler to its board as a Bluescape designee.

Risks

• Going concern — The 10-K states there is substantial doubt about the company's ability to continue as a going concern and that current cash will not fund long-term operations.
• Financing need — The company states it must raise substantial additional equity, debt, government or other funding and that financing may not be available on acceptable terms or at all.
• Pre-revenue development risk — The Fort Cady commercial-scale facility has not been built or funded, so projected boric acid production and co-product sales are not yet realized.
• Dilution risk — The 10-K notes that additional equity or debt issuance, or the possibility of it, could dilute existing shareholders and pressure the share price.

Outlook

Management points to the August 2025 PFS as defining a pathway to production, profitability and cash flow at Fort Cady, with optionality for later expansion phases. It cites recent commercial progress, including customer requests for proposals and early-stage offtake discussions after a March 2026 customer roadshow, and a non-binding offtake heads of agreement with a domestic industrial customer for boric acid announced in May 2026. The company also states boron was added to the U.S. Department of the Interior's 2025 Critical Minerals List on November 7, 2025. It continues to require financing to advance the project.